Phase II trial PD-L1/PD-1 blockade Avelumab (MSB0010718C) with Chemoradiotherapy for Locally Advanced Resectable T3b-4/N1-2 Rectal Cancer.

  • Gill, Sanjeev (Primary Chief Investigator (PCI))
  • Cross, Nikki (Project Manager)

Project: Research

Project Details

StatusFinished
Effective start/end date20/09/18 → 20/09/23